Skip to main content

The Impact of a Genomic Assay on Urologist Treatment Preference in Active Surveillance-Eligible Men

Thursday, March 9, 2023 | 12:00 PM - 1:00 PM CT
Robert H Lurie Medical Research Center, Hughes Auditorium, 303 E. Superior, Chicago, IL 60611 map it

Registration required.

**HYBRID EVENT: join us IN-PERSON or ONLINE. Please RSVP regardless and indicate your intended mode. The in-person event will be held in Hughes Auditorium of the Lurie Medical Research Building at 303 E. Superior; Chicago. Lunch will be provided for in person attendees on a first-come, first-served basis.**

Guest:
Adam B. Murphy, MD, MBA, MSCI
Assistant Professor of Urology & Preventive Medicine
Northwestern University Feinberg School of Medicine

Dr. Adam Murphy will summarize the results of a randomized controlled trial assessing the impact of a Genomic Assay on urologists and patients treatment preferences for favorable risk. prostate cancer.

For more public health news, events, and announcements, visit the IPHAM website: https://feinberg.northwestern.edu/ipham

This webinar is part of the Translational Applications in Public Health mini-series, which is a collaboration between the Institute for Public Health and Medicine (IPHAM) and the Northwestern University Clinical and Translational Sciences (NUCATS) Institute.

Audience

  • Faculty/Staff
  • Student
  • Public
  • Post Docs/Docs
  • Graduate Students

Contact

Institute for Public Health and Medicine (IPHAM)
Email

Interest

Add Event To My Group

Please sign-in